Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Eric Brunner, reader in epidemiology and public health (e.brunner@ucl.ac.uk)
  1. UCL Department of Epidemiology and Public Health, Royal Free and University College London Medical School, London WC1E 6BT

    Health recommendations conflict with concerns about dwindling supply

    Seventy five years ago, long chain omega 3 fatty acids were added to the list of essential nutrients. Later in the 20th century, the properties of marine polyunsaturated oils were linked with several health benefits, including protection from cardiovascular disease. However, a high quality systematic review published in this week's BMJ draws attention to uncertainties about some of the health benefits attributed to omega 3 fats.1

    The review shows that the evidence for a reduction in cardiovascular events and mortality is less conclusive than we believed. A previous meta-analysis indicates that mortality is reduced owing to fewer fatal coronary events among people ingesting omega 3 fatty acids,2 but the current review found no strong evidence of a reduction in combined cardiovascular events. The claim that omega 3 fats reduce the risk of cancer is not supported here or by another recent systematic review.3 For each health outcome there are too few trials with adequate allocation concealment, and too few cohort …

    Access to the full text of this article requires a subscription or payment

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    THIS WEEK'S POLL